Functional fatty-acid oxidation testing demonstrated elevations in the short-chain fatty-acid D3-C4 (Figures 5e and f)
Publication-ready graphs and full data reports
However, the substantial weight loss they facilitate does result in some loss of lean body mass, as occurs with any significant weight reduction
There is also substantial impact on overall lifespan with an estimated 520 years of life lost for individuals with a BMI 45 [9]
While there are no approved indications for using GLP-1 agonists specifically for the treatment of lipedema, these medications have shown numerous health benefits for women with dozens of medical conditions, such as Diabetes, Heart Disease, Kidney Disease, Parkinsons Disease, and Obesity, as well as for women without any existing medical problems